Literature DB >> 27321203

Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.

Chien-Chou Hsiao1, Jui-Chih Chang2, Lon-Yen Tsao3, Rei-Cheng Yang3, Hsiao-Neng Chen4, Cheng-Han Lee3, Ching-Yuang Lin5, Yi-Giien Tsai6.   

Abstract

BACKGROUND: Bronchopulmonary dysplasia (BPD) remains the most common complication of very low birth weight (VLBW) preterm infants, and inflammatory regulation plays a role in the development of the BPD. Interleukin-6 (IL-6) has an important role in airway inflammation and therefore can be used as a marker of airway injury. The study aimed to compare the changes between IL-6 and oxidative stress marker with 8-hydroxy-2'-deoxyguanosine (8-OHdG) from serum and tracheal aspiration (TA) in VLBW preterm infants following development of BPD.
METHODS: This birth cohort study enrolled 80 VLBW preterm infants, including 26 who developed BPD. All infants completed the study and survived at 36 weeks postmenstrual age. IL-6 and 8-OHdG concentrations from serum and TA on Day 1 and Day 28 after birth were measured using immunoassay.
RESULTS: IL-6 and 8-OHdG in serum and TA were higher in the BPD group than in the non-BPD group on the 1st day after birth (p < 0.05). The IL-6 and 8-OHdG levels in TA fluid were persistently increased on the 28th day of life in the BPD group (p < 0.05). The TA IL-6 was positively correlated with 8-OHdG levels on the 1st day (r = 0.64, p < 0.05) and 28th day of life (r = 0.76, p < 0.05). Based on receiver operating characteristic curves as a predictor of BPD development, TA IL-6 (cutoff, 456.8 pg/mg) had 81.5% sensitivity and 77.8% specificity, whereas TA 8-OHdG (cutoff, 4.4 ng/mg) had a sensitivity of 81.5% and a specificity of 64.4%.
CONCLUSION: Persistent inflammation with oxidative DNA damage in the respiratory tract may be a crucial mechanism in BPD.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  8-hydroxydeoxyguanosine; bronchopulmonary dysplasia; premature infant

Mesh:

Substances:

Year:  2016        PMID: 27321203     DOI: 10.1016/j.pedneo.2016.01.004

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  15 in total

Review 1.  New-generation intravenous fat emulsions and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.

Authors:  Xue Fan; Ying Tang; Jun Tang; Juan Chen; Jing Shi; Hua Wang; Bin Xia; Yi Qu; Dezhi Mu
Journal:  J Perinatol       Date:  2020-07-07       Impact factor: 2.521

2.  Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Dharmesh Hirani; Cristina M Alvira; Soula Danopoulos; Carlos Milla; Michele Donato; Lu Tian; Jasmine Mohr; Katharina Dinger; Christina Vohlen; Jaco Selle; Silke V Koningsbruggen-Rietschel; Verena Barbarino; Christian Pallasch; Stefan Rose-John; Margarete Odenthal; Gloria S Pryhuber; Siavash Mansouri; Rajkumar Savai; Werner Seeger; Purvesh Khatri; Denise Al Alam; Jörg Dötsch; Miguel A Alejandre Alcazar
Journal:  Eur Respir J       Date:  2022-02-17       Impact factor: 33.795

3.  [Effect of rhubarb on neonatal rats with bronchopulmonary dysplasia induced by hyperoxia].

Authors:  Ling-Ling Yin; Zhen-Zhi Ye; Li-Jun Tang; Liang Guo; Wei-Min Huang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

4.  Overexpression of AGT promotes bronchopulmonary dysplasis via the JAK/STAT signal pathway.

Authors:  Lili Shen; Tiancheng Zhang; Hongyan Lu
Journal:  Oncotarget       Date:  2017-10-10

5.  Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.

Authors:  Xin Chen; Xiaoqian Zhang; Jiahua Pan
Journal:  Med Sci Monit       Date:  2019-03-13

6.  Comparison of Oxidative Status of Human Milk, Human Milk Fortifiers and Preterm Infant Formulas.

Authors:  Luisa Pozzo; Simona Cirrincione; Rossella Russo; Magdalena Karamać; Ryszard Amarowicz; Alessandra Coscia; Sara Antoniazzi; Laura Cavallarin; Marzia Giribaldi
Journal:  Foods       Date:  2019-10-08

7.  Cytokines and Exhaled Nitric Oxide Are Risk Factors in Preterm Infants for Bronchopulmonary Dysplasia.

Authors:  Zhenjie Zhang; Wuchen Wu; Lian Hou; Jingjing Jiang; Weilin Wan; Zhenghong Li
Journal:  Biomed Res Int       Date:  2021-01-12       Impact factor: 3.411

Review 8.  Oxidative Stress and Respiratory Diseases in Preterm Newborns.

Authors:  Laura Cannavò; Serafina Perrone; Valeria Viola; Lucia Marseglia; Gabriella Di Rosa; Eloisa Gitto
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

9.  The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation.

Authors:  Dawid Szpecht; Janusz Gadzinowski; Irmina Nowak; Dorothy Cygan; Agnieszka Seremak-Mrozikiewicz; Grażyna Kurzawińska; Dariusz Madajczak; Krzysztof Drews; Marta Szymankiewicz
Journal:  Cent Eur J Immunol       Date:  2017-06-08       Impact factor: 2.085

10.  Long non-coding RNA MALAT1 targeting STING transcription promotes bronchopulmonary dysplasia through regulation of CREB.

Authors:  Jia-He Chen; Dan-Dan Feng; Yu-Fei Chen; Cai-Xia Yang; Chen-Xia Juan; Qian Cao; Xi Chen; Shuang Liu; Guo-Ping Zhou
Journal:  J Cell Mol Med       Date:  2020-08-18       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.